AstraZeneca PLC ADR Underperforms Friday When Compared To Competitors Despite Daily Gains

Dow Jones
08/02

DJ AstraZeneca PLC ADR Underperforms Friday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

The AstraZeneca PLC ADR $(AZN.UK)$ rallied 1.18% to $73.95 Friday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 2.24% to 20,650.13 and Dow Jones Industrial Average falling 1.23% to 43,588.58.

AstraZeneca PLC ADR closed 15.65% short of its 52-week high of $87.68, which the company achieved on August 30th.

The ADR underperformed when compared to some of its competitors Friday, as Eli Lilly & Co. (LLY) rose 3.01% to $762.33, Biogen Inc. (BIIB) rose 3.09% to $131.95, and Johnson & Johnson $(JNJ)$ rose 1.57% to $167.33.

Trading volume (9.7 M) eclipsed its 50-day average volume of 4.7 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 1, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

August 01, 2025 17:21 ET (21:21 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10